BRANDON O'QUINN: Open Payments
NPI 1295214096 · LIVINGSTON, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,498 in 36 payments from 16 companies in 2025. Trend: 2023 $867 · 2024 $1,324 · 2025 $1,498
Food & beverage: $1,498
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 6 | $234 |
| Endo USA, Inc. | 10 | $198 |
| AstraZeneca Pharmaceuticals LP | 2 | $145 |
| Insulet Corporation | 1 | $127 |
| Ardelyx, Inc. | 1 | $125 |
| Axsome Therapeutics, Inc. | 1 | $125 |
| ABBVIE INC. | 1 | $125 |
| KYOWA KIRIN, INC. | 1 | $125 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $76 |
| Ferring Pharmaceuticals Inc. | 2 | $51 |
Products named: XIAFLEX, LYNPARZA, OMNIPOD, Auvelity, VRAYLAR, RYBREVANT, IBSRELA, ERLEADA.
Industry payments across LA — which companies pay providers there.
